Hans van Houte
Director of Finance/CFO at NURIX THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/03/2024
Profile
Hans van Houte is currently the Chief Financial Officer at Nurix Therapeutics, Inc. He previously held positions as the Chief Accounting Officer, Treasurer & Controller at Vertex Pharmaceuticals, Inc., Vice President-Finance & Operations at Emergent Product Development Seattle, Chief Financial Officer at Igenica Biotherapeutics, Inc., and Managing Partner at Bionation LLC.
Mr. van Houte completed his undergraduate degree at Babson College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC.
0.14% | 20/03/2024 | 68,333 ( 0.14% ) | 1 M $ | 30/03/2024 |
Hans van Houte active positions
| Companies | Position | Start |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Director of Finance/CFO | 29/02/2016 |
Former positions of Hans van Houte
| Companies | Position | End |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Director of Finance/CFO | - |
| Bionation LLC | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | - |
Training of Hans van Houte
| Babson College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| NURIX THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
| Bionation LLC |
- Stock Market
- Insiders
- Hans van Houte
